- Research article
- Open Access
Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events
© Albuquerque et al; licensee BioMed Central Ltd. 2009
- Received: 05 March 2009
- Accepted: 17 June 2009
- Published: 17 June 2009
Plasmodium sporozoites migrate to the liver where they traverse several hepatocytes before invading the one inside which they will develop and multiply into thousands of merozoites. Although this constitutes an essential step of malaria infection, the requirements of Plasmodium parasites in liver cells and how they use the host cell for their own survival and development are poorly understood.
To gain new insights into the molecular host-parasite interactions that take place during malaria liver infection, we have used high-throughput microarray technology to determine the transcriptional profile of P. berghei-infected hepatoma cells. The data analysis shows differential expression patterns for 1064 host genes starting at 6 h and up to 24 h post infection, with the largest proportion correlating specifically with the early stages of the infection process. A considerable proportion of those genes were also found to be modulated in liver cells collected from P. yoelii- infected mice 24 and 40 h after infection, strengthening the data obtained with the in vitro model and highlighting genes and pathways involved in the host response to rodent Plasmodium parasites.
Our data reveal that host cell infection by Plasmodium sporozoites leads to a coordinated and sequential set of biological events, ranging from the initial stage of stress response up to the engagement of host metabolic processes and the maintenance of cell viability throughout infection.
- Differentially Express
- Differentially Express Gene
- Plasmodium Infection
- Parasite Development
Malaria remains a major health problem worldwide with 35% of the human population being at risk of becoming infected . The disease is caused by parasitic protozoa of the genus Plasmodium, which reach their mammalian host through the bite of an infected female Anopheles mosquito. The biological events that occur between the bite of a malaria-infected mosquito and the release of Plasmodium merozoites into the bloodstream are obligatory steps in the establishment of a malaria infection. Recently, our knowledge of the initial steps occurring in the skin immediately after mosquito bite increased (reviewed in ). We now also have a greater understanding not only of how sporozoites traverse the liver sinusoids and reach the hepatocytes before invading a final cell and forming a parasitophorous vacuole [3, 4], but also of how, inside hepatocytes, the so-called exoerythrocytic forms (EEFs) of the Plasmodium parasite develop and multiply. There, EEFs grow in size and undergo a series of morphological changes that culminates in the release of several thousand merozoites into the blood, where they will invade erythrocytes and cause the symptoms of the disease (reviewed in ). This gain of knowledge was only possible due to recent advances in imaging technologies , together with the development of tools for the genetic manipulation of Plasmodium species . However, in spite of these and other [8, 9] recent achievements little is known about the host molecules involved in Plasmodium liver development. This gap in our understanding is mainly due to the fact that the proportion of infected hepatic cells is very low both in vitro and in vivo. The reasons why hepatocytes are able to provide an appropriate environment for sporozoite development remain generally unknown. Given its clinically silent nature, the hepatic stage of Plasmodium life cycle constitutes an ideal target for potential anti-malarial vaccines or prophylactic treatments . Therefore, it is important to identify host hepatic factors that may influence liver infection and to understand their underlying molecular mechanisms, as a means to impair the parasite's development in the liver. Furthermore, an understanding of the molecular processes at play during the liver stage of malaria, may provide important information regarding the establishment and activation of hypnozoites, dormant forms of the parasite that occur with certain Plasmodium species and that are capable of causing a subsequent relapse in infection.
We took a genome-wide microarray approach to look into the liver-parasite molecular interactions and obtain a time-dependent profile of the transcriptional landscape of murine hepatoma cells infected by Plasmodium berghei sporozoites. Hepatoma cell lines constitute an invaluable and widely used tool to study the molecular aspects of hepatic infection by Plasmodium . This transcriptional analysis of the host cell response to Plasmodium infection and development revealed a coordinated and sequential set of biological events. We have identified several host genes and pathways with clearly modulated expression profiles as a result of infection and, thus, constitute a repertoire of novel host factors that are prime candidates for intervention strategies.
Cell infection for microarray analysis
Global gene expression analysis of hepatoma cells during Plasmodium infection
Expression profiling of P. berghei ANKA-infected and non-infected Hepa1-6 cells was performed at the four developmental time-points selected, using the Mouse Genome 430 2.0 Array (Affymetrix, Santa Clara, CA). To exclude potential false positives due to cross-hybridization of parasite RNA with mouse probes, cRNA obtained from axenic cultures of P. berghei sporozoites  at the same selected time points was pooled and hybridized as an extra sample on the Mouse 430 2.0 array. No cross-hybridization was found in the list of genes differentially expressed (DE) in P. berghei-infected cells with the parasite cRNA control array (data not shown).
The experimental design aimed at two complementary goals: (i) identifying host genes DE in Plasmodium infected compared to non-infected hepatoma cells, and (ii) following the patterns of differential expression across infection and parasite development within the cell. After robust normalization ~55% of the 45000 probesets represented on the array were classified as present by the MAS5.0 software (Affymetrix). Empirical Bayes moderated t-statistics ("limma" software package of R/Bioconductor ) were used to detect up- and down-regulated transcripts in response to Plasmodium infection at any of the four selected time-points. One thousand one hundred and seven probesets (or transcripts) representing 1064 unique genes proved to be significantly DE in at least one time point during the course of Hepa1-6 cells infection by GFP+ P. berghei ANKA (see Additional File 1). This set of data was used in all subsequent analyses.
In order to evaluate the overall structure of the data, we have plotted the first three principal components of a principal component analysis (PCA), capturing the overall variance of the samples in 3 dimensions (Figure 2B). This analysis clearly separates the data into 4 subgroups, clustering together the biological replicates, segregating infected from non-infected cells, and separating the samples by time after infection. Intriguingly, PCA separates genes expressed at 12 h p.i. in infected cells (Figure 2B, red dots) from those expressed at 6, 18 and 24 h p.i. (Figure 2B, black, green and blue dots, respectively). In non-infected cells, early to mid-term cellular events (6–12 h p.i, turquoise and pink dots, respectively) can be differentiated from later ones (18–24 h p.i., yellow and grey dots, respectively).
Time-course independent host cell responses to Plasmodium infection
Interestingly, 24 genes (32 transcripts) playing a role in transcription/translation, transport, signaling, apoptosis, cell growth and differentiation, proteolysis, cytoskeleton, and steroid biosynthesis are DE at all times in infected cells compared to non-infected ones (Figure 4B and see Additional File 2). Although no common pathway or gene ontology can be clearly identified for the whole set, 14 genes are up-regulated in all the time points assessed. They include three endoplasmic reticulum (ER)-stress related genes: trib3, nupr1 and ddit3 that can act in concert to induce apoptosis under the right stimuli  as shown during Hepatitis C virus infection . As a matter of fact two of these genes, trib3 and nupr1, systematically ranked in the top 5 of genes DE throughout parasite development (see Additional File 3). However, the same ER-stress induced complex, involving Atf4, which binds to Ddit3 through a DNAzip binding domain, has been shown to regulate the heme oxygenase 1 (hmox-1) gene expression as a defense mechanism against oxidative stress . Interestingly, atf4 is also up-regulated in our analysis from 6 to 18 h p.i, as is hmox-1 (top ranking at 18 h p.i; see Additional Files 4 and 1), suggesting a clear definitive and sustained response to oxidative stress caused by the parasite (see Additional File 1). Those ER-stress induced factors are attractive candidates to stimulate Hmox-1 expression, which we have shown to promote P. berghei liver infection . Trib3 has also a clear negative modulatory effect on the insulin signaling pathway in hepatocytes that is responsible for glucose homeostasis . Whether these metabolic pathways are important for Plasmodium development inside the hepatocyte remains to be elucidated.
It is also compelling to find that some host molecules are down-regulated in infected cells throughout the entire period of the experiment. Among those 10 transcripts, there are: 2 G-protein coupled receptors, which have a role in signal transduction; protein C, which is a regulator of the blood coagulation cascade; maf, which encodes an oncoprotein promoting cell differentiation; and 2 solute carriers, MCT4 and ZIP8, which, if down-modulated, have been shown respectively to help restore calcium homeostasis  and impair mitochondrion function in response to TNFα . Mct4 and zip8 rank in the top 5 DE genes in our analysis, along with an ABC transporter (abcd2) that is also down-regulated during the whole course of parasite development, and trib3 and nupr1 (see above) that are up-regulated at all the time points assessed (see Additional file 3 and 1).
Time-course specific host cell responses to Plasmodium infection
Similarly to T. gondii [25, 26], P. berghei parasites manipulate host cell NF-κB signaling. NF-κB transcription factors have been proposed to act as a "first responder" to the cellular stimuli caused by traversal of host cells by Plasmodium prior to invasion . To identify targets or interacting molecules, we cross-checked the repertoire of cytokines and chemokines produced by infected liver cells with known target genes of NF-κB http://people.bu.edu/gilmore/nf-kb/target/index.html. Ccl2, a member of the CC subfamily of chemokines, is up-regulated throughout parasite development and ccl5 (rantes) is up-regulated between 6 and 12 h p.i (see Additional Files 1 and 5). Cxcl1 (gro-α), and cxcl2 are members of the CXC subfamily of chemokines that are also up-regulated, from 6 to 18 h p.i. or at all time points, respectively (see Additional Files 3, 1 and 5). Additional NF-κB-induced factors DE at early stages of infection include cell adhesion molecules icam1, and vcam1, as well as the transcription factors nfkb1b and nfkb1z (see Additional File 1).
Interestingly, it has been previously shown that T. gondii also manipulates the MAPK signaling pathway through LPS/TLR4 engagement . Although in the present experiment none of the Toll-Like Receptors were DE, the MAPK pathway seems to be up-regulated through the production of gadd45α/β and γ from 6 to 24 h p.i. (see Additional File 4), mkp from 6 to 12 h p.i. and ikk from 18 to 24 h p.i. (see Additional Files 1 and 5). The MAPK pathway was also shown to be up-regulated in B-type hepatocellular carcinoma and during Hepatitis B Virus (HBV) infection [29, 30], indicating that up-regulation of signal transduction-related genes is not pathogen-specific. This suggests that cell traversal or invasion by sporozoites may engage several host receptors and that these events constitute, perhaps not surprisingly, a stress-inducing stimulus for the cells, leading to a cascade of signaling events through chemokines and cytokines that might have positive or negative effects on the establishment of the liver infection. In fact, one such gene is hmox-1, which is up-regulated in infected cells at all the time points assessed, significantly so at 18 h p.i. (see Additional Files 4, 1 and 5), as well as in macrophages and Kupffer cells in the liver . As mentioned above, Hmox-1 is a major stress-response molecule that we have shown to promote liver infection by controlling the extent of the host inflammatory response . Interestingly, Hmox-1 has pronounced antiviral activity in HBV infection  while it can promote Mycobacterium tuberculosis latent infection in host .
At 12 h p.i., with 287 DE genes, the parasite seems to primarily modulate the host cell's transcriptome towards biosynthetic pathways including carbohydrate and fatty acid metabolism. This correlates well with host responses observed during early T. gondii infection that has been reported to be a general reaction to stress rather than a specific parasite induced response . Genes involved in cellular homeostasis, transport and cell communication are also modulated following productive invasion.
At 18 h of parasite development 451 DE genes playing a role in lipid metabolism (35 genes), amino acid and nucleic acid metabolism (39 genes), as well as cell cycle (58 genes) and catalytic activity (33 genes) are significantly modulated (Figure 5; see Additional Files 1 and 5). This picture may suggest that once a host cell is successfully infected by Plasmodium, its resources remain engaged in energy production and homeostasis, possibly in an attempt to cope with the imbalance caused by the intracellular presence of the parasite. Indeed, the liver stage parasite goes through an extensive proliferative phase during this period, likely requiring large amounts of proteins and lipids to produce tens of thousands of merozoites that will in turn invade the red blood cells (reviewed in ). Consistent with this notion, our analysis shows that the parasite's presence down-modulates signaling trough the PPAR and adipocytokine pathways around 12 to 18 h p.i. (Figure 5B, purple and blue stacked bars) leading to increased lipid metabolic processes (Figure 5A, purple and blue stacked bars; Figure 6B; see Additional File 5). It has been described that a parasitophorous vacuole membrane protein encoded by the parasite, UIS3, specifically binds to the liver-fatty-acid binding protein (L-FABP) . By engaging L-FABP, the parasite would reduce PPAR activity, resulting in an increase in fatty acids available to it. As such, it is tempting to speculate that the parasite influences host cell metabolism in its own interest. Also, transport molecules are engaged from 6 to 18 h p.i Whether this is important to provide the developing parasite with the components it requires for its rapid proliferation and/or host cell survival remains to be established (Figure 5A; see Additional File 5).
At 24 h p.i., with 163 DE genes, glutathione metabolism is the major host pathway modulated by the parasite (Figure 5B). Glutathione metabolism and transport participate in many cellular reactions including antioxidant defence of the cell, drug detoxification and cell signalling (involved in the regulation of gene expression, apoptosis and cell proliferation). Alterations in glutathione concentration have also been shown to be a common feature of many pathological conditions including diabetes, cancer, AIDS, neurodegenerative and liver diseases . Therefore, one can speculate that the parasite stimulates the glutathione pathway to help sustain the host cell in the final stages of development.
Finally, it is interesting to note that genes involved in cell differentiation and death, through the p53 signalling pathway, are DE throughout the whole time span covered in this study (Figure 5A and 5B, pink, purple, blue and green stacked bars; see Additional Files 5). From the earliest stages of infection, cell survival and apoptosis mechanisms are actively at play (Figure 6C, mainly down-regulated transcripts in infected cells in early time points). Malaria hepatic infection involves the activation of the tyrosine kinase HGF receptor (MET) by secreted HGF  and down modulation of MET leads to a decrease in infection [8, 35]. In our analysis, met is over-expressed at 6 h p.i (see Additional File 4). It has been shown that the malaria parasite exploits MET not as a primary binding site, but as a mediator of signals that make the host susceptible to infection. This signalling pathway might influence host actin cytoskeleton  and apoptosis  during infection (Figure 6D and 6C, respectively) and play an important role in the survival of the infected cell. Indeed, P. berghei-infected hepatocytes are more resistant to apoptosis induced by different stimuli throughout infection [36, 37], and require an actively developing parasite . Hence, one might therefore suggest that pro- and anti-apoptotic genes are actively modulated throughout infection, in a constant struggle between the infected cell's tendency to undergo apoptosis and the parasite's need for the host cell to survive (Figure 6A and 6C).
Similarities between the rodent malaria species P. yoelii and P. berghei
A complementary in vivo assay was carried out on liver cells from mice infected with P. yoelii at 24 h, when most liver stage parasites are at a small early schizont stage and have undergone two to four rounds of nuclear division, and 40 h p.i., when most liver stage parasites are large late schizonts and have undergone up to 13 rounds of nuclear division , and compared to the findings described above. We found that 67% of genes DE in P. berghei-infected Hepa1-6 cells are also expressed in P. yoelii-infected livers. Although parasite development in cell culture and in vivo is known to proceed at different rates , and two different microarray platforms were used, for two different parasites species, a sizeable 42% of the genes DE in P. berghei infected cells are also found DE in P. yoelii-infected livers in at least one time point (see Additional File 6). Twenty-six transcripts are found DE in both experiments with the highest agreement in terms of up or down-modulation (16 transcripts) and common time point (10 transcripts at 24 h p.i.) (Grey shaded boxes in Additional Files 6 and 7). It is reassuring to find that some of those transcripts have been discussed above as identified in top ranking positions during P. berghei infection and include ccl2, cxcl2, G protein-coupled receptor gpr137B, and gpr155, nr4a2, abcd2, hmox-1 and klf4. These findings corroborate the validity and strength of our in vitro model, and highlight those genes or the pathways they are involved in as common and important factors in host response to rodent parasites.
In summary, we have used a microarray-based approach to profile the host cell response to a malaria sporozoite infection in a time course experiment. Our data shows that host cell response to Plasmodium can broadly be divided into 3 major components, including an initial stress response to the presence of the parasite, a subsequent engagement of host cell metabolic processes and a constant management of host cell viability. Our data suggest that, following an initial stage in which the infected cells respond to the stress caused by the presence of the parasite, the outcome of infection may depend on the parasite's ability to engage the cell's resources to its own benefit thereby fulfilling its molecular needs for multiplication. On the other hand, Plasmodium seems to influence the host cell's survival for as long as the parasite requires an intracellular shelter for expansion. Targeting host factors during the initial stages of parasite development has already proven to modulate the fate of infection . Our data reveal, for the first time, a number of host genes, from modulators of the immune system to genes involved in lipid metabolism, which may constitute possible targets for future drug development strategies. It is therefore tempting to speculate that those genes may constitute possible candidates for the design of new strategies for future anti-malarial intervention. Indeed, targeting host proteins specifically required for infection/maintenance of the parasite, but non-essential to the host itself, holds several key advantages. Most importantly it offers inherently lower susceptibility of those drugs to induce resistance in the parasite, arguably the biggest problem faced in all infectious disease fields today. Furthermore, targeting host factors also offers much higher potential for accelerated therapeutics discovery or development through synergies with ongoing output from mainstream disease pipelines. Host proteins are more likely to have been the focus of previous or even ongoing therapeutic development work in other fields, thus opening the possibility of finding anti-malarial activities as second medical uses for existing drugs.
Parasites and hepatoma cell culture
Parasites were maintained by alternate cyclic passages in mosquitoes and mice. GFP+ Plasmodium berghei ANKA sporozoites were obtained from dissection of infected Anopheles stephensi mosquito salivary glands in RPMI 1640 (Gibco) medium. Hepa1-6 cells were cultured in DMEM supplemented with 10% Foetal Calf Serum (Gibco), 1% Penicillin/Streptomycin (Gibco) and 1 mM glutamine (Gibco) and maintained at 37°C with 5% CO2.
Cell infection and sample collection
In vitro infections of Hepa1-6 cells for microarray experiments were carried out by adding 2 × 105 P. berghei sporozoites per well to cells seeded 24 h earlier in 24- well plates (2 × 105 cells/well). Salivary glands from non-infected mosquitoes were extracted and the same volume of the extraction solution was added to cells used as controls. All the in vitro infection plates were spun down at 3000 rpm for 5 min and incubated at 37°C with 5% CO2. Following incubation, the medium was aspirated, cells were washed with PBS and 100 μl Trypsin (Gibco) was added. After 3 min incubation at 37°C and 5% CO2, cells were washed with 10% FCS in PBS, collected and centrifuged at 800 rpm for 5 min at 4°C. The supernatant was removed and the pellet was resuspended in 2% FCS in PBS.
Cell sorting and RNA extraction
Hepa1-6 cells infected with GFP-expressing P. berghei sporozoites  were collected at 6, 12, 18 and 24 hr post-infection and then selected using fluorescence activated cell-sorting (FACS) on a High speed cell sorter; Dako-Cytomation; Mo-Flo MLS leading to ~90% purity. Non-infected samples were collected using a similar protocol. After sorting, cells were collected in cell lysate (buffer RLT, Qiagen), vortexed for 1 min and stored at -80°C. Total RNA was extracted from the sorted cells with Rneasy MicroKit (Qiagen), according to the manufacturer's instructions. RNA concentration and quality of all replicates were determined on a NanoDrop ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies) and only samples with a 260/280 ratio greater than 1.8 were further processed. Each sample was diluted to be within the dynamic range of the RNA 6000 Nano Assay Kit (Agilent Technologies), with a target of 100 ng. The Nano Labchip protocol was followed according to the manufacturer's instructions and all samples were evaluated in a Bioanalyser 2100 (Agilent Technologies). Samples with the highest concentration, two distinct 18 S and 28 S subunit peaks and no evidence of degradation were further processed. For each time point two independent biological replicates were obtained.
Hepatoma cell RNA hybridization
The GeneChip® Mouse Expression 430 2.0 array contains 45000 probesets, covering 39000 transcripts and variants from over 34000 well characterized mouse genes. Duplicate cultures, infection processes and sorting events were analyzed for each condition (4 time points, 2 conditions, 2 replicates). Total RNA (100 ng) was used to generate biotin-labelled cRNA using the Two-cycle protocol as described by Affymetrix (Santa Clara, CA). Washing, staining and scanning of the DNA chips was performed as recommended by the manufacturer. Signal intensity for each feature on the arrays was determined using the 70th percentile method provided by GCOS software (Affymetrix). All microarray procedures were performed at the Instituto Gulbenkian de Ciência (Oeiras, Portugal) Affymetrix Core facility 144.
Liver samples preparation
Total RNA from sorted liver stage-infected hepatocytes was isolated from PyGFP-infected BALB/c mice as described in . RNA from liver stage-infected hepatocytes was isolated at two time points post-infection: 24 and 40 h p.i. As control, RNA from hepatocytes isolated from mock-infected mice was also isolated following the same procedure. Total RNA was then subjected to two rounds of linear amplification using the Amino Allyl Message Amp II aRNA Amplification Kit (Ambion) according to manufacturer's directions. The quality of total and amplified RNAs was examined with the RNA 6000 Nano Assay kit (Agilent Technologies) and the amount of RNA in the samples was assessed on a NanoDrop ND-1000 UV-Vis Spectrophotometer prior to microarray hybridization (NanoDrop Technologies). For each time point two independent biological replicates were obtained.
Liver's microarray analysis
Customised 60-mer mouse microarrays were manufactured by NimbleGen (Madison, WI) and contain 188608 probes representing 32650 mouse transcripts. On average, each transcript is represented by 6 probes. To minimize the cross-hybridization with parasite RNAs, probes were screened against annotated genes (PlasmoDB version 5.0) and TIGR Gene Indices (Release 5.0) from both malaria parasites P. yoelii and P. berghei. To incorporate the latest annotation information, probes were re-mapped to Entrez Gene http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene prior to data analysis. Entrez Gene is NCBI's gene-centric database and each record represents a single gene from a given organism. Probes were mapped to mouse genes by blasting against mouse transcripts from NCBI's Reference Sequence (RefSeq) collection and all sequences in mouse UniGene clusters (all downloaded from NCBI on May, 2007). In total, 158685 probes were perfectly matched to 31473 mouse transcripts. 157412 probes were specifically mapped to 19203 mouse genes (8 probes per gene on average) and 1273 probes were specifically mapped to 366 transcripts which were not linked to an annotated mouse gene. Those un-mapped probes were excluded in this analysis. The possible reasons for not mapping those probes are either current annotation is not complete, or some of annotated sequence records retired after the array was designed.
Data analysis was performed using R/Bioconductor . Microarrays from each platform were pre-processed separately using a Robust Multiarray Averaging program (RMA; . The expression values were calculated using the "affycoretools" package package (MacDonald, JW. Affycoretools: Functions useful for those doing repetitive analyses with Affymetrix GeneChips. R package version 1.14.0). The differential expression was assessed and variability estimated by fitting a linear model to the data that fully models the systematic part of each gene, using the "limma" package . By fitting a linear model to the data set, the "limma" package ranks significantly DE genes in infected vs. non-infected cells for each of the time points. From the "limma" output, log-fold changes from one condition compared with another and B-statistic (log-odds that a gene is differentially expressed) can be obtained and used to determine up- and down-regulation of genes. Fold changes of 1.5 × and B-statistics >0 for probesets were used as cut-off. Gene sets enrichment was analyzed using "GOstats"  and "GSEABase" packages (Morgan, M., Falcon, S. and Gentleman, R. GSEABase: Gene set enrichment data structures and methods. R package version 1.4.0). Heatmaps and PCA were plotted using the "gplots" and "scatterplot3d" packages (Warnes, GR. Includes R source code and/or documentation contributed by Bolker, B. and Lumley, T. gplots: Various R programming tools for plotting data. R package version 2.6.0; 
Quantitative real time RT-PCR (qRT-PCR)
SYBR® Green PCR Master Mix (Applied Biosystems) was used according to the manufacturer's instructions to quantify the expression of nuclear protein 1 (nupr1), tribbles homolog 3 (trib3), vascular cell adhesion molecule (vcam1), ATP-binding cassette, sub-family D (abcd2), cytochrome P450 1a1 (cyp1a1) and stearoyl-coenzyme A desaturase 2 (scd2). Gene expression was normalized against the expression of mouse hypoxanthine guanine phosphoribosyl transferase 1 (hprt1) as the housekeeping standard. Primers were designed using the Oligo 6 Primer Analysis Software (Molecular Biology Insights) and sequences were as presented in Additional File 8. Total RNA from the non-infected and P. berghei-infected hepatocytes (independent samples were collected at 6 h p.i., sorted and RNA extracted as described before) was reverse-transcribed to single strand cDNA using the AMV Reverse Transcriptase (Roche Applied Science) protocol. The single strand cDNA from the reverse transcriptase reaction was amplified by real-time quantitative fluorogenic PCR. The reaction was performed on an ABIPrism 7000 Sequence Detection System (Applied Biosystems) with a total volume of 25 μl using the following cycling parameters: one cycle of 2 min at 50°C, one cycle of 10 min at 95°C, 45 cycles of 15 s at 95°C, 1 min at 57°C. The reaction consisted on SYBR® Green PCR Master Mix (12.5 μl), 0.8 μl of forward and reverse primer, 1 μl of template and 10.7 μl of water per sample. All reactions were carried out in duplicate. RNA expression level fold changes were calculated using the ABIPrism 7000 SDS Software. Non-infected sample transcripts levels were used as the gene expression base line.
The authors are thankful to Jörg Becker and Júlia Lobato for their help in the microarrays experiment and to Gunnar Mair for critically reading the manuscript. This work is supported by Fundação para a Ciência e Tecnologia (Grant 38563/MGI/2001 to MMM) and European Science Foundation (EURYI to MMM) and partially funded by a Seattle Biomedical Research Institute Innovation award (to SHIK). MP is a holder of a Ciência 2007 position of the Portuguese Ministry of Science and Higher Education. MMM is a Howard Hughes Medical Institute International Scholar and a BioMalPar Affiliated Member.
- Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, Snow RW: The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med. 2008, 5 (2): e38-10.1371/journal.pmed.0050038.PubMed CentralView ArticlePubMedGoogle Scholar
- Sinnis P, Zavala F: The skin stage of malaria infection: biology and relevance to the malaria vaccine effort. Future Microbiol. 2008, 3: 275-278. 10.2217/174609220.127.116.115.View ArticlePubMedGoogle Scholar
- Frevert U, Engelmann S, Zougbede S, Stange J, Ng B, Matuschewski K, Liebes L, Yee H: Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol. 2005, 3 (6): e192-10.1371/journal.pbio.0030192.PubMed CentralView ArticlePubMedGoogle Scholar
- Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, Nussenzweig RS, Nussenzweig V, Rodriguez A: Migration of Plasmodium sporozoites through cells before infection. Science. 2001, 291 (5501): 141-144. 10.1126/science.291.5501.141.View ArticlePubMedGoogle Scholar
- Prudencio M, Rodriguez A, Mota MM: The silent path to thousands of merozoites: the Plasmodium liver stage. Nat Rev Microbiol. 2006, 4 (11): 849-856. 10.1038/nrmicro1529.View ArticlePubMedGoogle Scholar
- Heussler V, Doerig C: In vivo imaging enters parasitology. Trends Parasitol. 2006, 22 (5): 192-195. 10.1016/j.pt.2006.03.001.View ArticlePubMedGoogle Scholar
- Janse CJ, Ramesar J, Waters AP: High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc. 2006, 1 (1): 346-356. 10.1038/nprot.2006.53.View ArticlePubMedGoogle Scholar
- Prudencio M, Rodrigues CD, Hannus M, Martin C, Real E, Goncalves LA, Carret C, Dorkin R, Rohl I, Jahn-Hoffmann K, et al: Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog. 2008, 4 (11): e1000201-10.1371/journal.ppat.1000201.PubMed CentralView ArticlePubMedGoogle Scholar
- Rodrigues CD, Hannus M, Prudencio M, Martin C, Goncalves LA, Portugal S, Epiphanio S, Akinc A, Hadwiger P, Jahn-Hofmann K, et al: Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe. 2008, 4 (3): 271-282. 10.1016/j.chom.2008.07.012.View ArticlePubMedGoogle Scholar
- Cunha-Rodrigues M, Prudencio M, Mota MM, Haas W: Antimalarial drugs – host targets (re)visited. Biotechnol J. 2006, 1 (3): 321-332. 10.1002/biot.200500038.View ArticlePubMedGoogle Scholar
- Prudencio M, Rodrigues CD, Ataide R, Mota MM: Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry. Cell Microbiol. 2007, 10 (1): 218-224.PubMedGoogle Scholar
- Mota MM, Rodriguez A: Plasmodium yoelii: efficient in vitro invasion and complete development of sporozoites in mouse hepatic cell lines. Exp Parasitol. 2000, 96 (4): 257-259. 10.1006/expr.2000.4570.View ArticlePubMedGoogle Scholar
- Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, Keur van der M, Linden van der R, Sinden RE, Waters AP, Janse CJ: A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol. 2004, 137 (1): 23-33. 10.1016/j.molbiopara.2004.04.007.View ArticlePubMedGoogle Scholar
- Kaiser K, Camargo N, Kappe SH: Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells. J Exp Med. 2003, 197 (8): 1045-1050. 10.1084/jem.20022100.PubMed CentralView ArticlePubMedGoogle Scholar
- Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5 (10): R80-10.1186/gb-2004-5-10-r80.PubMed CentralView ArticlePubMedGoogle Scholar
- Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, Giroux V, Malicet C, Villuendas R, Gironella M, Gonzalez-Feria L, et al: The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell. 2006, 9 (4): 301-312. 10.1016/j.ccr.2006.03.005.View ArticlePubMedGoogle Scholar
- Benali-Furet NL, Chami M, Houel L, De Giorgi F, Vernejoul F, Lagorce D, Buscail L, Bartenschlager R, Ichas F, Rizzuto R, et al: Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene. 2005, 24 (31): 4921-4933. 10.1038/sj.onc.1208673.View ArticlePubMedGoogle Scholar
- He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM, Alam J: Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem. 2001, 276 (24): 20858-20865. 10.1074/jbc.M101198200.View ArticlePubMedGoogle Scholar
- Epiphanio S, Mikolajczak SA, Goncalves LA, Pamplona A, Portugal S, Albuquerque S, Goldberg M, Rebelo S, Anderson DG, Akinc A, et al: Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. Cell Host Microbe. 2008, 3 (5): 331-338. 10.1016/j.chom.2008.04.003.View ArticlePubMedGoogle Scholar
- Du K, Herzig S, Kulkarni RN, Montminy M: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science. 2003, 300 (5625): 1574-1577. 10.1126/science.1079817.View ArticlePubMedGoogle Scholar
- Sirvent P, Mercier J, Vassort G, Lacampagne A: Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle. Biochem Biophys Res Commun. 2005, 329 (3): 1067-1075. 10.1016/j.bbrc.2005.02.070.View ArticlePubMedGoogle Scholar
- Besecker B, Bao S, Bohacova B, Papp A, Sadee W, Knoell DL: The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia. Am J Physiol Lung Cell Mol Physiol. 2008, 294 (6): L1127-1136. 10.1152/ajplung.00057.2008.View ArticlePubMedGoogle Scholar
- Fouts AE, Boothroyd JC: Infection with Toxoplasma gondii bradyzoites has a diminished impact on host transcript levels relative to tachyzoite infection. Infect Immun. 2007, 75 (2): 634-642. 10.1128/IAI.01228-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Kim SK, Fouts AE, Boothroyd JC: Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J Immunol. 2007, 178 (8): 5154-5165.View ArticlePubMedGoogle Scholar
- Molestina RE, Sinai AP: Host and parasite-derived IKK activities direct distinct temporal phases of NF-kappaB activation and target gene expression following Toxoplasma gondii infection. J Cell Sci. 2005, 118 (Pt 24): 5785-5796. 10.1242/jcs.02709.View ArticlePubMedGoogle Scholar
- Shapira S, Harb OS, Margarit J, Matrajt M, Han J, Hoffmann A, Freedman B, May MJ, Roos DS, Hunter CA: Initiation and termination of NF-kappaB signaling by the intracellular protozoan parasite Toxoplasma gondii. J Cell Sci. 2005, 118 (Pt 15): 3501-3508. 10.1242/jcs.02428.View ArticlePubMedGoogle Scholar
- Torgler R, Bongfen SE, Romero JC, Tardivel A, Thome M, Corradin G: Sporozoite-mediated hepatocyte wounding limits Plasmodium parasite development via MyD88-mediated NF-kappa B activation and inducible NO synthase expression. J Immunol. 2008, 180 (6): 3990-3999.View ArticlePubMedGoogle Scholar
- Lee CW, Bennouna S, Denkers EY: Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages. Infect Immun. 2006, 74 (3): 1916-1923. 10.1128/IAI.74.3.1916-1923.2006.PubMed CentralView ArticlePubMedGoogle Scholar
- Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, et al: Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 2002, 62 (14): 3939-3944.PubMedGoogle Scholar
- Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, et al: Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA. 2001, 98 (26): 15089-15094. 10.1073/pnas.241522398.PubMed CentralView ArticlePubMedGoogle Scholar
- Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, Hosel M, Schirmacher P, Tiegs G: Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology. 2007, 133 (4): 1156-1165. 10.1053/j.gastro.2007.07.021.View ArticlePubMedGoogle Scholar
- Shiloh MU, Manzanillo P, Cox JS: Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe. 2008, 3 (5): 323-330. 10.1016/j.chom.2008.03.007.PubMed CentralView ArticlePubMedGoogle Scholar
- Mikolajczak SA, Jacobs-Lorena V, MacKellar DC, Camargo N, Kappe SH: L-FABP is a critical host factor for successful malaria liver stage development. Int J Parasitol. 2007, 37 (5): 483-489. 10.1016/j.ijpara.2007.01.002.View ArticlePubMedGoogle Scholar
- Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI: The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem. 2007, 113 (4–5): 234-258. 10.1080/13813450701661198.View ArticlePubMedGoogle Scholar
- Carrolo M, Giordano S, Cabrita-Santos L, Corso S, Vigario AM, Silva S, Leiriao P, Carapau D, Armas-Portela R, Comoglio PM, et al: Hepatocyte growth factor and its receptor are required for malaria infection. Nat Med. 2003, 9 (11): 1363-1369. 10.1038/nm947.View ArticlePubMedGoogle Scholar
- Leiriao P, Albuquerque SS, Corso S, van Gemert GJ, Sauerwein RW, Rodriguez A, Giordano S, Mota MM: HGF/MET signalling protects Plasmodium-infected host cells from apoptosis. Cell Microbiol. 2005, 7 (4): 603-609. 10.1111/j.1462-5822.2004.00490.x.View ArticlePubMedGoogle Scholar
- Sand van de C, Horstmann S, Schmidt A, Sturm A, Bolte S, Krueger A, Lutgehetmann M, Pollok JM, Libert C, Heussler VT: The liver stage of Plasmodium berghei inhibits host cell apoptosis. Mol Microbiol. 2005, 58 (3): 731-742. 10.1111/j.1365-2958.2005.04888.x.View ArticlePubMedGoogle Scholar
- Leiriao P, Mota MM, Rodriguez A: Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. J Infect Dis. 2005, 191 (10): 1576-1581. 10.1086/429635.View ArticlePubMedGoogle Scholar
- Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, Daly TM, Bergman LW, Kappe SH: A combined transcriptome and proteome survey of malaria parasite liver stages. Proc Natl Acad Sci USA. 2008, 105 (1): 305-310. 10.1073/pnas.0710780104.PubMed CentralView ArticlePubMedGoogle Scholar
- Preiser PR, Khan S, Costa FT, Jarra W, Belnoue E, Ogun S, Holder AA, Voza T, Landau I, Snounou G, et al: Stage-specific transcription of distinct repertoires of a multigene family during Plasmodium life cycle. Science. 2002, 295 (5553): 342-345. 10.1126/science.1064938.View ArticlePubMedGoogle Scholar
- Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003, 4 (2): 249-264. 10.1093/biostatistics/4.2.249.View ArticlePubMedGoogle Scholar
- Wettenhall JM, Smyth GK: limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics. 2004, 20 (18): 3705-3706. 10.1093/bioinformatics/bth449.View ArticlePubMedGoogle Scholar
- Falcon S, Gentleman R: Using GOstats to test gene lists for GO term association. Bioinformatics. 2007, 23 (2): 257-258. 10.1093/bioinformatics/btl567.View ArticlePubMedGoogle Scholar
- Ligges U, Mächler M: Scatterplot3d – an R Package for Visualizing Multivariate Data. Journal of Statistical Software. 2003, 8 (11): 1-20.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.